Developer docs
API playgroundTry for free, no card

Search company profiles

Magentiq Eye Ltd

Full company profile

uuid0000s41

Namestring
Magentiq Eye Ltd
Legal namestring
MAGENTIQ EYE Ltd.
Websiteurl
magentiq.com
Company typeenum
Private
Founded yearint
2014
Descriptiontext

Magentiq Eye Ltd is an Israel-based medical device company founded in 2014 that develops MAGENTIQ-COLO™, a software platform providing AI-augmented decision support during colonoscopy procedures. The product applies deep-learning models to the live video stream from standard endoscopy towers, performing real-time computer-aided detection (CADe) of colorectal polyps, computer-aided diagnosis (CADx) for polyp size estimation and characterization, and computer-aided quality (CAQ) metrics such as Boston Bowel Preparation Score assessment and automated cecum detection. Training data covers 65+ million frames drawn from 3,500+ full procedure videos, and pivotal validation was published in The Lancet Digital Health based on a 950+ patient randomized multicenter trial across ten centers in Europe, the US, and Israel.

MAGENTIQ-COLO is regulated as a Class II medical device, holding CE Mark since 2021, FDA 510(k) clearance since 2023, and ISO 13485:2016 certification. The platform integrates with the four leading endoscopy equipment vendors (Olympus, Fujinon, Pentax, Sonoscape) and ships in two hardware form factors (processor-only and portable on-cart). The company monetizes through a monthly rental subscription model, with additional revenue tied to procedure volume where reimbursement structures reward higher adenoma detection.

Commercially, Magentiq pursues a hybrid go-to-market: direct enterprise field sales in Europe and the United States layered on top of an exclusive US distribution agreement with PENTAX Medical (HOYA Group) that went live in October 2024. Customers are gastroenterology clinics, hospitals, and healthcare systems conducting colorectal cancer screening. Following a Series A round in July 2025 led by aMoon, the company is scaling US and European salesforce and broadening the platform into procedural quality documentation following the January 2026 release of tool detection and CAQ features.

Short descriptiontext

Magentiq Eye Ltd develops MAGENTIQ-COLO™, an FDA-cleared and CE-marked AI platform that performs real-time polyp detection, characterization, and quality documentation during colonoscopy, serving gastroenterology clinics and hospitals in Europe, the United States, and Israel via a monthly rental subscription model.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersHaifa, Israel
HQ citystring
Haifa
HQ countrystring
Israel
HQ regionstring
Middle East
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
AI colonoscopy software, polyp detection system, computer-aided detection, gastroenterology AI platform, medical imaging AI
Industry2 codes
PRIMARYHLAHADAB
Endoscopy Systems & Accessories (Scopes, Cameras, Light Sources, Insufflation)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Surgical Instruments, Endoscopy & OR Equipment
SECONDARYHLAHADAD
Surgical Visualization & OR Video Integration (4K/3D, Recording, Routing)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Surgical Instruments, Endoscopy & OR Equipment
NAICS code2 codes
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
  • Medical Equipment and Supplies Manufacturing3391
SIC code1 code
  • Surgical & Medical Instruments & Apparatus3841
Product category
Gastroenterology AI Software
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model2 records
1Monthly Rental Software Model
TypeSubscription Recurring
Description

Software as a service model with monthly rental pricing. Low upfront cost with always-updated software and flexible commitment terms. Hardware options include processor-only unit or fully equipped portable cart.

magentiq.com
2Procedure-Based Revenue
TypeTransaction Fee
Description

Additional income from more colonoscopies performed and more adenomas resected. In US and some European countries, medical centers are reimbursed further if polyps are resected.

magentiq.com
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Technology or R&D, Personnel, Marketing or Sales, Operations, Infrastructure, Supply Chain
Pricing details2 tiers
1Processor-Only Option
ModelSubscriptionBilling cadenceMonthly
Notes

Computer unit attaches and mounts to existing hardware for space-and cost-saving implementation.

magentiq.com
2On-Cart Portable Option
ModelSubscriptionBilling cadenceMonthly
Notes

Fully equipped portable cart with computer processor and touch screen for flexible deployment.

magentiq.com
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 record
1MAGENTIQ-COLO™
Description

AI-powered colonoscopy platform with computer-aided detection (CADe) for real-time polyp detection and computer-aided diagnosis (CADx) capabilities supporting polyp size estimation and characterization.

magentiq.com
Core offering1 text field

Magentiq Eye Ltd develops MAGENTIQ-COLO™, an AI-powered software platform that performs real-time computer-aided detection (CADe) and computer-aided diagnosis (CADx) of polyps during colonoscopy procedures. The system acquires video output from existing endoscopy towers (Olympus, Fujinon, Pentax, Sonoscape), highlights suspicious lesions with bounding boxes, and adds automated quality metrics. It is sold as a monthly-rental subscription to gastroenterology departments of hospitals and clinics, with optional hardware (processor-only unit or portable cart).

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 6 values shown
  • 26% relative increase in adenoma detection rate (ADR)
+5 more records
Product overview1 text field

Magentiq Eye Ltd offers a single unified product platform called MAGENTIQ-COLO™ for AI-powered gastroenterology diagnostics. The platform provides computer-aided detection (CADe) for real-time polyp detection, computer-aided diagnosis (CADx) for polyp characterization and size estimation, and computer-aided quality (CAQ) metrics for procedural documentation. The system is available in two regulatory versions: an FDA-cleared version for the U.S. market with tool detection, and a CE-marked version for Europe with additional quality features including BBPS assessment and automated cecum detection. The product integrates with major endoscopy systems (Olympus, Fujinon, Pentax, Sonoscape) and operates via a monthly rental business model.

Product and service1 record
1MAGENTIQ-COLO™
CategoryGastroenterology AI Software
Description

AI-aided colonoscopy software platform that performs real-time polyp detection and analysis during colonoscopy procedures. It integrates with major endoscopy systems (Olympus, Fujinon, Pentax, Sonoscape), highlights suspected polyps with bounding boxes on the procedure screen, and provides automated polyp size estimation, characterization, and procedural quality metrics (BBPS, cecum detection). It is targeted at gastroenterology departments in hospitals and clinics.

Scale indicator9 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2024-05-18
Description

HOYA Group company PENTAX Medical announced partnership intention with MAGENTIQ EYE to distribute MAGENTIQ-COLO AI-assisted lesion detection device in the US market. Formal agreement expected with distribution beginning October 1, 2024. System demonstrated at DDW in Washington DC. Partnership in field of AI in Gastroenterology with further collaboration and strategic partnerships to be examined.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers9 records
TypeDirect peer
Description

Medtronic distributes the GI Genius AI polyp detection system (acquired from Cosmo Pharmaceuticals) — the most direct and best-capitalized competitor to MAGENTIQ-COLO in AI-aided colonoscopy, serving the same gastroenterology customer base with similar CADe functionality.

TypeDirect peer
Description

Iterative Health is a venture-backed digital health company applying AI/ML to gastroenterology, including polyp detection and procedure quality — directly comparable in stage, AI-in-GI focus, and clinical validation approach to Magentiq.

TypeDirect peer
Description

Satisfai Health develops AI applications for real-time polyp detection and characterization during colonoscopy and other GI procedures — a direct competitor in the same CADe/CADx clinical workflow and customer segment.

TypeBroad incumbent
Description

Fujifilm is one of the four major endoscopy system manufacturers (alongside Olympus, Pentax, Sonoscape) and offers its own AI colonoscopy feature (CAD EYE) integrated into its endoscopy towers — making it both a compatible integration partner and a competing AI vendor.

TypeBroad incumbent
Description

Olympus is the largest global endoscopy system manufacturer and is also Magentiq's largest compatible-integration partner. Olympus has invested in AI endoscopy features, positioning it as a broad incumbent that could either compete with or accelerate third-party AI like MAGENTIQ-COLO.

6HOYA (Pentax Medical)
TypeBroad incumbent
Description

HOYA's Pentax Medical is Magentiq's exclusive US distribution partner and one of the four major endoscopy OEMs. As a broad incumbent, Pentax also pursues its own AI endoscopy initiatives, creating a partnership/competitive duality.

TypeEmerging player
Description

Virgo applies AI to endoscopic video for data capture, procedure analysis, and clinical decision support in GI procedures — overlapping thematically with Magentiq's quality-metrics and structured-reporting features (BBPS, cecum detection).

TypeEmerging player
Description

Wision AI develops AI-based polyp detection software for colonoscopy and is pursuing regulatory clearances for global markets — a comparable CADe pure-play competitor, though with a regional focus on China and select international markets.

TypeBroad incumbent
Description

NEC has a medical AI business that includes computer-aided detection and diagnostic imaging solutions for endoscopy and colonoscopy. As a broad incumbent in medical AI, NEC represents both a competitor and a potential partner for hospital-wide AI deployments.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers8 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration4 records

Each record includes

Title, Type, Description, Source

AI capability8 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles12 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds13 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors12 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Magentiq Eye Ltd

Gastroenterology AI Softwaremagentiq.com

Magentiq Eye Ltd develops MAGENTIQ-COLO™, an FDA-cleared and CE-marked AI platform that performs real-time polyp detection, characterization, and quality documentation during colonoscopy, serving gastroenterology clinics and hospitals in Europe, the United States, and Israel via a monthly rental subscription model.

What Magentiq Eye Ltd does

Magentiq Eye Ltd is an Israel-based medical device company founded in 2014 that develops MAGENTIQ-COLO™, a software platform providing AI-augmented decision support during colonoscopy procedures. The product applies deep-learning models to the live video stream from standard endoscopy towers, performing real-time computer-aided detection (CADe) of colorectal polyps, computer-aided diagnosis (CADx) for polyp size estimation and characterization, and computer-aided quality (CAQ) metrics such as Boston Bowel Preparation Score assessment and automated cecum detection. Training data covers 65+ million frames drawn from 3,500+ full procedure videos, and pivotal validation was published in The Lancet Digital Health based on a 950+ patient randomized multicenter trial across ten centers in Europe, the US, and Israel.

MAGENTIQ-COLO is regulated as a Class II medical device, holding CE Mark since 2021, FDA 510(k) clearance since 2023, and ISO 13485:2016 certification. The platform integrates with the four leading endoscopy equipment vendors (Olympus, Fujinon, Pentax, Sonoscape) and ships in two hardware form factors (processor-only and portable on-cart). The company monetizes through a monthly rental subscription model, with additional revenue tied to procedure volume where reimbursement structures reward higher adenoma detection.

Commercially, Magentiq pursues a hybrid go-to-market: direct enterprise field sales in Europe and the United States layered on top of an exclusive US distribution agreement with PENTAX Medical (HOYA Group) that went live in October 2024. Customers are gastroenterology clinics, hospitals, and healthcare systems conducting colorectal cancer screening. Following a Series A round in July 2025 led by aMoon, the company is scaling US and European salesforce and broadening the platform into procedural quality documentation following the January 2026 release of tool detection and CAQ features.

Magentiq Eye Ltd firmographics

Firmographics
Name
Magentiq Eye Ltd
Legal name
MAGENTIQ EYE Ltd.
Website
https://magentiq.com
Company type
Private
Founded year
2014
Operating status
Operating
Headcount range
11–50 employees
Short description
Magentiq Eye Ltd develops MAGENTIQ-COLO™, an FDA-cleared and CE-marked AI platform that performs real-time polyp detection, characterization, and quality documentation during colonoscopy, serving gastroenterology clinics and hospitals in Europe, the United States, and Israel via a monthly rental subscription model.
Ownership category
akta.pro rank

Magentiq Eye Ltd industry classification

Industry
Product category
Gastroenterology AI Software
NAICS
Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Medical Equipment and Supplies Manufacturing (3391)
SIC
Surgical & Medical Instruments & Apparatus (3841)
akta.pro industry
PRIMARYHLAHADAB
Endoscopy Systems & Accessories (Scopes, Cameras, Light Sources, Insufflation)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Surgical Instruments, Endoscopy & OR Equipment
SECONDARYHLAHADAD
Surgical Visualization & OR Video Integration (4K/3D, Recording, Routing)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Surgical Instruments, Endoscopy & OR Equipment

Keywords

  • AI colonoscopy software
  • Polyp detection system
  • Computer-aided detection
  • Gastroenterology AI platform
  • Medical imaging AI

Where Magentiq Eye Ltd is headquartered

Location

Headquarters

HQ city
Haifa
HQ country
Israel
HQ region
Middle East

Offices1 record

Markets served

Magentiq Eye Ltd business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Technology or R&D, Personnel, Marketing or Sales, Operations, Infrastructure, Supply Chain

Revenue model

  1. Monthly Rental Software Model: Software as a service model with monthly rental pricing. Low upfront cost with always-updated software and flexible commitment terms. Hardware options include processor-only unit or fully equipped portable cart.
  2. Procedure-Based Revenue: Additional income from more colonoscopies performed and more adenomas resected. In US and some European countries, medical centers are reimbursed further if polyps are resected.

Pricing tiers

ModelBillingPrice
SubscriptionMonthlyProcessor-Only Option
SubscriptionMonthlyOn-Cart Portable Option

Go-to-market motion2 records

Distribution channels2 records

Marketing channels8 records

Magentiq Eye Ltd product offering

Product offering

Core offering

Magentiq Eye Ltd develops MAGENTIQ-COLO™, an AI-powered software platform that performs real-time computer-aided detection (CADe) and computer-aided diagnosis (CADx) of polyps during colonoscopy procedures. The system acquires video output from existing endoscopy towers (Olympus, Fujinon, Pentax, Sonoscape), highlights suspicious lesions with bounding boxes, and adds automated quality metrics. It is sold as a monthly-rental subscription to gastroenterology departments of hospitals and clinics, with optional hardware (processor-only unit or portable cart).

Product overview

Magentiq Eye Ltd offers a single unified product platform called MAGENTIQ-COLO™ for AI-powered gastroenterology diagnostics. The platform provides computer-aided detection (CADe) for real-time polyp detection, computer-aided diagnosis (CADx) for polyp characterization and size estimation, and computer-aided quality (CAQ) metrics for procedural documentation. The system is available in two regulatory versions: an FDA-cleared version for the U.S. market with tool detection, and a CE-marked version for Europe with additional quality features including BBPS assessment and automated cecum detection. The product integrates with major endoscopy systems (Olympus, Fujinon, Pentax, Sonoscape) and operates via a monthly rental business model.

Differentiator

Problem solved

Functional benefit

Brands

  • MAGENTIQ-COLO™: AI-powered colonoscopy platform with computer-aided detection (CADe) for real-time polyp detection and computer-aided diagnosis (CADx) capabilities supporting polyp size estimation and characterization.

Products and services

  • MAGENTIQ-COLO™ AI-aided colonoscopy software platform that performs real-time polyp detection and analysis during colonoscopy procedures. It integrates with major endoscopy systems (Olympus, Fujinon, Pentax, Sonoscape), highlights suspected polyps with bounding boxes on the procedure screen, and provides automated polyp size estimation, characterization, and procedural quality metrics (BBPS, cecum detection). It is targeted at gastroenterology departments in hospitals and clinics.

Quantifiable outcome

  • 26% relative increase in adenoma detection rate (ADR)
  • +5 more outcomes

Companies that use Magentiq Eye Ltd

Customer profile

Named customers8 records

Segments2 records

Ideal customer profiles2 records

Magentiq Eye Ltd technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration4 records

AI capability8 records

Feature6 records

Magentiq Eye Ltd partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • PENTAX Medical (HOYA Group)coreChannel Partner/ Reseller/ Distributor · 18 May 2024HOYA Group company PENTAX Medical announced partnership intention with MAGENTIQ EYE to distribute MAGENTIQ-COLO AI-assisted lesion detection device in the US market. Formal agreement expected with distribution beginning October 1, 2024. System demonstrated at DDW in Washington DC. Partnership in field of AI in Gastroenterology with further collaboration and strategic partnerships to be examined.

Scale indicators9 records

Recent moves7 records

Expansion highlights6 records

Magentiq Eye Ltd competitors and assessment

Company assessment

Direct peers

  • Medtronic: Medtronic distributes the GI Genius AI polyp detection system (acquired from Cosmo Pharmaceuticals) — the most direct and best-capitalized competitor to MAGENTIQ-COLO in AI-aided colonoscopy, serving the same gastroenterology customer base with similar CADe functionality.
  • Iterative Health: Iterative Health is a venture-backed digital health company applying AI/ML to gastroenterology, including polyp detection and procedure quality — directly comparable in stage, AI-in-GI focus, and clinical validation approach to Magentiq.
  • Satisfai Health: Satisfai Health develops AI applications for real-time polyp detection and characterization during colonoscopy and other GI procedures — a direct competitor in the same CADe/CADx clinical workflow and customer segment.

Broad incumbents

  • Fujifilm Healthcare: Fujifilm is one of the four major endoscopy system manufacturers (alongside Olympus, Pentax, Sonoscape) and offers its own AI colonoscopy feature (CAD EYE) integrated into its endoscopy towers — making it both a compatible integration partner and a competing AI vendor.
  • Olympus Corporation: Olympus is the largest global endoscopy system manufacturer and is also Magentiq's largest compatible-integration partner. Olympus has invested in AI endoscopy features, positioning it as a broad incumbent that could either compete with or accelerate third-party AI like MAGENTIQ-COLO.
  • HOYA (Pentax Medical): HOYA's Pentax Medical is Magentiq's exclusive US distribution partner and one of the four major endoscopy OEMs. As a broad incumbent, Pentax also pursues its own AI endoscopy initiatives, creating a partnership/competitive duality.
  • NEC Corporation: NEC has a medical AI business that includes computer-aided detection and diagnostic imaging solutions for endoscopy and colonoscopy. As a broad incumbent in medical AI, NEC represents both a competitor and a potential partner for hospital-wide AI deployments.

Emerging players

  • Virgo Surgical Video Solutions: Virgo applies AI to endoscopic video for data capture, procedure analysis, and clinical decision support in GI procedures — overlapping thematically with Magentiq's quality-metrics and structured-reporting features (BBPS, cecum detection).
  • Wision AI: Wision AI develops AI-based polyp detection software for colonoscopy and is pursuing regulatory clearances for global markets — a comparable CADe pure-play competitor, though with a regional focus on China and select international markets.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Magentiq Eye Ltd social profiles

Digital presence

Magentiq Eye Ltd compliance and trust

Trust signal

Compliance3 records

Magentiq Eye Ltd financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Magentiq Eye Ltd leadership team

Management profile

Number of profiles

Profiles12 records

Magentiq Eye Ltd funding detail

Funding detail

Funding overview

Funding rounds13 records

Investors12 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Magentiq Eye Ltd M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Magentiq Eye Ltd

What does Magentiq Eye Ltd do?

Magentiq Eye Ltd develops MAGENTIQ-COLO™, an AI-powered software platform that performs real-time computer-aided detection (CADe) and computer-aided diagnosis (CADx) of polyps during colonoscopy procedures. The system acquires video output from existing endoscopy towers (Olympus, Fujinon, Pentax, Sonoscape), highlights suspicious lesions with bounding boxes, and adds automated quality metrics. It is sold as a monthly-rental subscription to gastroenterology departments of hospitals and clinics, with optional hardware (processor-only unit or portable cart).

Is Magentiq Eye Ltd a public or private company?

Magentiq Eye Ltd is a private company. It is classified as venture growth investor backed and is currently operating.

When was Magentiq Eye Ltd founded?

Magentiq Eye Ltd was founded in 2014. It employs 11 to 50 people.

Where is Magentiq Eye Ltd based?

Magentiq Eye Ltd is headquartered in Haifa, Israel, in the Middle East region.

How does Magentiq Eye Ltd make money?

Two revenue lines are on record. Monthly Rental Software Model is the primary driver. The others are procedure-Based Revenue.

Who are Magentiq Eye Ltd's main competitors?

Direct peers on record are Medtronic, Iterative Health and Satisfai Health. Broad incumbents are Fujifilm Healthcare, Olympus Corporation, HOYA (Pentax Medical) and NEC Corporation. Emerging players are Virgo Surgical Video Solutions and Wision AI.

Does Magentiq Eye Ltd have an API?

No public API is recorded for Magentiq Eye Ltd.

What industry is Magentiq Eye Ltd in?

Magentiq Eye Ltd's product category is Gastroenterology AI Software. Its primary akta.pro industry code is HLAHADAB, Endoscopy Systems & Accessories (Scopes, Cameras, Light Sources, Insufflation), with a secondary code of HLAHADAD, Surgical Visualization & OR Video Integration (4K/3D, Recording, Routing). Its NAICS code is 334510 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Medical Device NetworkPENTAX broadens MAGENTIQ EYE partnership for global AI colonoscopyJapan-based PENTAX Medical, part of the HOYA Group, has expanded its collaboration with MAGENTIQ EYE to market, distribute and support the MAGENTIQ-COLO AI colonoscopy system across Europe, the Middle East, Africa, Japan, Asia-Pacific and Latin America. The AI is integrated into PENTAX's INSPIRA EPK-i8020c and IMAGINA EPK-i5500c video processors, with MAGENTIQ-COLO showing a 26% relative increase in adenoma detection and a 48% reduction in miss rate in a Lancet Digital Health trial.YahooPENTAX Medical and MAGENTIQ EYE Expand Global Partnership to Advance AI-Assisted Colonoscopy WorldwidePENTAX Medical, a HOYA Group company, announced on August 26, 2026 an expansion of its partnership with MAGENTIQ EYE, extending an agreement that covered the United States to include EMEA, JAPAC and LATAM. MAGENTIQ-COLO will be integrated into PENTAX's INSPIRA EPK-i8020c and IMAGINA EPK-i5500c video processors, with PENTAX marketing and distributing the solution. The AI's performance was validated in a multicenter trial published in The Lancet Digital Health, showing a 26% relative increase in adenoma detection rate and a 48% relative decrease in adenoma miss rate.PR Newswire APACPENTAX Medical and MAGENTIQ EYE Expand Global Partnership to Advance AI-Assisted Colonoscopy WorldwidePENTAX Medical, a HOYA Group company, announced on August 26, 2026 an expansion of its partnership with MAGENTIQ EYE, extending an agreement that covered the United States to include EMEA, JAPAC and LATAM. MAGENTIQ-COLO will be integrated into the INSPIRA EPK-i8020c and IMAGINA EPK-i5500c video processors, with PENTAX Medical marketing and distributing the solution. The AI platform showed a 26% relative increase in adenoma detection rate and a 48% relative decrease in adenoma miss rate in a multicenter trial published in The Lancet Digital Health.PR NewswirePENTAX Medical and MAGENTIQ EYE Expand Global Partnership to Advance AI-Assisted Colonoscopy WorldwidePENTAX Medical, a HOYA Group company, announced on August 26, 2026 an expansion of its partnership with MAGENTIQ EYE, extending an agreement that covered the United States to include EMEA, JAPAC and LATAM. MAGENTIQ-COLO will integrate into PENTAX's INSPIRA EPK-i8020c and IMAGINA EPK-i5500c video processors, with a cited multicenter trial showing a 26% relative increase in adenoma detection rate and a 48% relative decrease in miss rate.PR NewswirePENTAX Medical and MAGENTIQ EYE Expand Global Partnership to Advance AI-Assisted Colonoscopy WorldwidePENTAX Medical and MAGENTIQ EYE expanded their partnership to include EMEA, JAPAC, and LATAM, integrating MAGENTIQ-COLO AI into PENTAX's INSPIRA and IMAGINA video processors. The AI solution was validated in a trial showing a 26% relative increase in adenoma detection rate and a 48% relative decrease in adenoma miss rate.HIT ConsultantMAGENTIQ EYE Secures Funding to Advance AI-Powered Gastroenterology DiagnosticsMAGENTIQ EYE completed a Series A funding round led by aMoon, with participation from existing investors. The funds will support development and commercial growth of its AI-powered colonoscopy software, MAGENTIQ-COLO, which improves polyp detection. The company is also in clinical trials for GI diagnostic tools.PR NewswireMAGENTIQ EYE sichert sich ein Serie-A-Investment unter Führung von aMoon, um die Zukunft der KI-gestützten Gastroenterologie voranzutreibenMAGENTIQ EYE LTD, an AI-powered gastroenterology decision-support software company based in Haifa, Israel, announced the successful completion of its Series A funding round led by aMoon, Israel's largest HealthTech-focused investment fund. The round also included participation from Norgine Ventures BV, Nina Capital, Namarel Ventures SL, Nova Capital, and private investors Sake Bosch and Roon Doornink, with aMoon partner Roy Wiesner joining the company's board. The funding will support commercialization of its FDA and CE-approved MAGENTIQ-COLO colonoscopy software in the US and European markets, as well as further development of AI diagnostic tools for gastrointestinal conditions.PR NewswireMAGENTIQ EYE obtiene una inversión de Serie A liderada por aMoonMAGENTIQ EYE LTD., an Israeli AI-powered gastroenterology decision-support software company, announced the successful completion of its Series A funding round, led by aMoon, Israel's largest HealthTech-focused venture capital fund. The financing will support the commercialization of its FDA and CE-approved MAGENTIQ-COLO™ software in the United States and Europe, as well as continued development of advanced AI diagnostic tools for gastrointestinal diseases. Roy Wiesner, a partner at aMoon, will join MAGENTIQ EYE's board of directors as part of the investment.PR NewswireMAGENTIQ EYE obtient un investissement de série A organisé par aMoon afin d'assurer l'avenir de la gastro-entérologie active par l'IAMAGENTIQ EYE LTD, a Haifa-based AI-powered gastroenterology software company, announced the successful closing of its Series A funding round led by aMoon, Israel\'s largest health technology investment fund, with participation from Norgine Ventures BV, Nina Capital, Namarel Ventures SL, Nova Capital, and private investors. The funding will support US and European commercialization of its FDA and CE-approved MAGENTIQ-COLO software, which enhances polyp detection during colonoscopies, as well as continued development of AI diagnostics for conditions including ulcerative colitis and esophageal Barrett\'s dysplasia.AInvestHOYA's Strategic Endoscope Ecosystem Play: Vertical Integration and AI-Driven Dominance in Medical TechHOYA acquired Wassenburg Medical in late 2023 and partnered with MAGENTIQ-EYE, integrating AI diagnostics into its endoscopy ecosystem. The global endoscopy market is valued at over $25 billion and growing 7% annually, with MAGENTIQ-COLO™ targeting colorectal cancer screening. HOYA aims to capture recurring revenue from service contracts and consumables.